Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial  Lancet. 2025;406(10505):821–831
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40849139

Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary Medical Journal of Australia. 2025;223(5):268–276
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40721348

Autopsy of a Patient with Hepatic Pleural Effusion Complicated by Pleurisy Associated with Sjögren’s Syndrome  Internal Medicine. 2025;64(16):2489–2493
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971293

Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis  Annals of Medicine. 2025;57(1):2445192
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39707826

Clinical Variables That Predict Liver-related Events in Steatotic Liver Disease Diagnosed by a Liver Biopsy  Internal Medicine. 2025;64(16):2425–2432
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39924239

Definition, investigation and management of gastrointestinal dystonia in children and young people with neurodisability Archives of Disease in Childhood. 2025;110(9):742–750
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40306763

Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials  BMC Medicine. 2025;23(1):502
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40866968

Efficacy and safety of tislelizumab in patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis  Journal of the Egyptian National Cancer Institute. 2025;37(1):56
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40850957

Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care  Journal of Internal Medicine. 2025;298(3):173–187
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40518766

Frequent Missed Opportunities for Earlier Diagnosis of Advanced-Stage Colorectal or Lung Cancer  JAMA Intern Med. 2025;185(9):1102–1108
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40690229

Helicobacter pylori-positive Colorectal MALT Lymphoma with Repeated Metachronous Recurrence after a Complete Response to Eradication Therapy and Regression after a Watch-and-wait Strategy Internal Medicine. 2025;64(16):2452–2457
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971291

Hepatic Sarcoidosis Mimicking a Metastatic Tumor  Internal Medicine. 2025;64(16):2439–2445
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971299

Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-Analysis  Liver Int. 2025;45(9):e70287
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40851509

Incidence of Hepatobiliary Malignancies in Primary Sclerosing Cholangitis: Systematic Review and Meta-analysis  Clinical Gastroenterology and Hepatology. 2025;23(10):1695–1709.e13
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39709139

Irritable Bowel Syndrome  Annals of Internal Medicine. 2025;178(8):Itc113–itc128
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40789179

Liver metastases in breast cancer: [(18)F]FDG and radioembolization as strategies for diagnosis and treatment  Expert Review of Medical Devices. 2025;22(9):999–1008
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40579741

Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-Analysis  American Journal of Medicine. 2025;138(9):1238–1247.e4
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40316227

Measures to prevent esophageal stenosis are necessary after endoscopic submucosal dissection for early esophageal cancer lesions with a circumferential ratio of 75%-99%: a retrospective case analysis  Postgraduate Medical Journal. 2025;101(1199):820–827
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39850008

Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis  BMC Gastroenterology. 2025;25(1):613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40846917

Population Health Colorectal Cancer Screening Strategies in Adults Aged 45 to 49 Years: A Randomized Clinical Trial JAMA. 2025;334(9):778–787
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40758331

The prognostic value of indoleamine 2,3-dioxygenase in colorectal cancer: a systematic review and meta-analysis  BMC Gastroenterology. 2025;25(1):603
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40836217

Rapid Development of a Hemorrhagic Hyperplastic Polyp in a Patient with Evolving Autoimmune Gastritis after Helicobacter pylori Eradication  Internal Medicine. 2025;64(16):2446–2451
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39924242

Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis  Annals of Medicine. 2025;57(1):2455539
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39834076

Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial  Lancet. 2025;406(10504):719–730
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40818852

Significance of an Early Diagnosis of Autoimmune Gastritis in Nonelderly Patients with Type 1 Diabetes Mellitus and Autoimmune Thyroid Disease  Internal Medicine. 2025;64(17):2587–2591
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971298